Adult split liver transplantation: A PRISMA-compliant Chinese single-center retrospective case-control study. Issue 51 (18th December 2020)

• Record Type: Journal Article
• Authors: Kong, Lingxiang; Lv, Tao; Yang, Jian; Jiang, Li; Yang, Jiayin
• Other Names: Sung. Wen-Wei section editor.
• Is Part Of: Medicine. Volume 99:Issue 51(2020)
• Publication Date: 2020-12-18
• Subjects: donation after brain death -- liver transplantation -- split liver transplantation; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000023750
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Abstract: Although pediatric split liver transplantation (SLT) has been proven safe and the waitlist mortality rate has been successfully reduced, the safety of adult SLT has not been confirmed. Using 1:2 matching, 47 recipients who underwent adult SLT were matched to 94 of 743 recipients who underwent adult whole graft liver transplantation (WGLT). Eventually, 141 recipients were included in the case-control study. Subgroup analysis of 43 recipients in the SLT group was performed based on the presence of the middle hepatic vein (MHV) in the grafts. No significant differences in 5-year survival (80.8% vs 81.6%, P = .465) were observed between the adult SLT and WGLT groups. However, compared to recipients in the WGLT group, those in the SLT group had more Clavien–Dindo grade III-V complications, longer hospitalization duration, and higher mortality within 45 days. Furthermore, on multivariate analysis, 45-day postoperative mortality in recipients in the SLT group was mainly affected by hyperbilirubinemia within postoperative day (POD) 7–14, surgery time, and intraoperative blood loss. Subgroup analysis showed no significant differences in hyperbilirubinemia within POD 7–14, complications, and survival rate between SLT MHV(+) and SLT MHV [−] . Adult SLT is safe and effective based on long-term survival rates; however, a reduction in the incidence of short-term complications is required. Non-obstructive hyperbilirubinemia within POD 7 to 14 is an independent predictor of short-term mortality after SLT. Abstract : Supplemental Digital Content is available in the text